1
|
Abo-Samaha MI, Sharaf MM, El Nahas AF, Odemuyiwa SO. Innate immune response to double-stranded RNA in American heritage chicken breeds. Poult Sci 2024; 103:103318. [PMID: 38064884 PMCID: PMC10757028 DOI: 10.1016/j.psj.2023.103318] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2023] [Revised: 11/18/2023] [Accepted: 11/20/2023] [Indexed: 01/02/2024] Open
Abstract
Backyard poultry flocks that employ heritage breeds of chicken play a crucial role in the maintenance of poultry pathogens of economic and zoonotic importance. This study examined innate immunity to viral pathogens in heritage chicken breeds using a model of viral double-stranded RNA (dsRNA). Following intraperitoneal injection of high molecular weight (HMW) -poly(I:C)/Lyovec into 4-wk-old chicks, we evaluated gene expression in peripheral blood mononuclear cells (PBMCs) and splenocytes. There was a significant difference across breeds in the expression of IL-4, IL-12p40, IFNγ, and B-cell activating factor (BAFF) in the spleen. In PBMCs, a significant difference in IFN-α expression was seen across breeds. Approximately 57% of IFN-α transcripts in PBMCs was explained by levels of expression of MDA5 transcripts. Using flow cytometry, we showed that only monocytes/macrophages (KUL01+ cells) expressed the scavenger receptor CD163. Regression analysis showed that 42% of fold change in CD163 expression on PBMCs was explained by breed (P < 0.0004). In general, breeds that responded to HMW-poly(I:C) by showing higher upregulation of IFNγ, IL-1β, and IL-12p40 transcripts in the spleen, and higher IFNα transcripts in peripheral blood, expressed less CD163 on blood monocytes. These findings suggest a genetic basis for the response of chickens to double-stranded RNA. Surface expression of the scavenger receptor CD163 in PBMCs following injection of high molecular weight poly(I:C) may be a rapid method to select chickens for breeding based on innate immune response to viral dsRNA.
Collapse
Affiliation(s)
- Magda I Abo-Samaha
- Department of Pathobiology, College of Veterinary Medicine, Tuskegee University, Tuskegee, AL 36088; Department of Animal Husbandry and Animal Wealth Development, Faculty of Veterinary Medicine, Alexandria University, Alexandria, Egypt
| | - Mohammed M Sharaf
- Department of Animal Husbandry and Animal Wealth Development, Faculty of Veterinary Medicine, Alexandria University, Alexandria, Egypt
| | - Abeer F El Nahas
- Department of Animal Husbandry and Animal Wealth Development, Faculty of Veterinary Medicine, Alexandria University, Alexandria, Egypt
| | - Solomon O Odemuyiwa
- Department of Pathobiology, College of Veterinary Medicine, Tuskegee University, Tuskegee, AL 36088; Department of Veterinary Pathobiology, College of Veterinary Medicine, University of Missouri, Columbia, MO 65211, USA.
| |
Collapse
|
2
|
Martin RA, Tate AT. Pleiotropy promotes the evolution of inducible immune responses in a model of host-pathogen coevolution. PLoS Comput Biol 2023; 19:e1010445. [PMID: 37022993 PMCID: PMC10079112 DOI: 10.1371/journal.pcbi.1010445] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2022] [Accepted: 02/23/2023] [Indexed: 04/07/2023] Open
Abstract
Components of immune systems face significant selective pressure to efficiently use organismal resources, mitigate infection, and resist parasitic manipulation. A theoretically optimal immune defense balances investment in constitutive and inducible immune components depending on the kinds of parasites encountered, but genetic and dynamic constraints can force deviation away from theoretical optima. One such potential constraint is pleiotropy, the phenomenon where a single gene affects multiple phenotypes. Although pleiotropy can prevent or dramatically slow adaptive evolution, it is prevalent in the signaling networks that compose metazoan immune systems. We hypothesized that pleiotropy is maintained in immune signaling networks despite slowed adaptive evolution because it provides some other advantage, such as forcing network evolution to compensate in ways that increase host fitness during infection. To study the effects of pleiotropy on the evolution of immune signaling networks, we used an agent-based modeling approach to evolve a population of host immune systems infected by simultaneously co-evolving parasites. Four kinds of pleiotropic restrictions on evolvability were incorporated into the networks, and their evolutionary outcomes were compared to, and competed against, non-pleiotropic networks. As the networks evolved, we tracked several metrics of immune network complexity, relative investment in inducible and constitutive defenses, and features associated with the winners and losers of competitive simulations. Our results suggest non-pleiotropic networks evolve to deploy highly constitutive immune responses regardless of parasite prevalence, but some implementations of pleiotropy favor the evolution of highly inducible immunity. These inducible pleiotropic networks are no less fit than non-pleiotropic networks and can out-compete non-pleiotropic networks in competitive simulations. These provide a theoretical explanation for the prevalence of pleiotropic genes in immune systems and highlight a mechanism that could facilitate the evolution of inducible immune responses.
Collapse
Affiliation(s)
- Reese A. Martin
- Department of Biological Sciences, Vanderbilt University, Nashville, Tennessee, United States of America
- Evolutionary Studies Initiative, Vanderbilt University, Nashville, Tennessee, United States of America
| | - Ann T. Tate
- Department of Biological Sciences, Vanderbilt University, Nashville, Tennessee, United States of America
- Evolutionary Studies Initiative, Vanderbilt University, Nashville, Tennessee, United States of America
| |
Collapse
|
3
|
Nanayakkara M, Lania G, Maglio M, Auricchio R, De Musis C, Discepolo V, Miele E, Jabri B, Troncone R, Auricchio S, Barone MV. P31-43, an undigested gliadin peptide, mimics and enhances the innate immune response to viruses and interferes with endocytic trafficking: a role in celiac disease. Sci Rep 2018; 8:10821. [PMID: 30018339 PMCID: PMC6050301 DOI: 10.1038/s41598-018-28830-y] [Citation(s) in RCA: 33] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2017] [Accepted: 07/02/2018] [Indexed: 12/18/2022] Open
Abstract
Celiac disease (CD) is an autoimmune disease characterized by inflammation of the intestinal mucosa due to an immune response to wheat gliadins. Some gliadin peptides are resistant to intestinal digestion (e.g., A-gliadin P31–43) and induce a stress/innate immune response, but the reason why they are dangerous in the intestines of patients with CD is unknown. In the present study, P31–43 activated IFN-α, a mediator of the innate immune response in CD, in the intestine of subjects with CD and an enterocyte cell line, CaCo-2. P31–43 cooperated with a viral ligand to activate the TLR7 pathway by interfering with endocytic trafficking. Based on these results, the vesicular pathway regulates the innate/inflammatory response to viral ligands and bioactive dietary peptides. Suggesting that together with viral infections, alimentary proteins able to mimic and potentiate the innate immune response to viruses, can trigger an autoimmune disease such as CD.
Collapse
Affiliation(s)
- Merlin Nanayakkara
- Department of Translational Medical Science (Section of Paediatrics) and ELFID (European Laboratory for the Investigation of Food-Induced Disease), University of Naples, Federico II, Naples, 80131, Italy
| | - Giuliana Lania
- Department of Translational Medical Science (Section of Paediatrics) and ELFID (European Laboratory for the Investigation of Food-Induced Disease), University of Naples, Federico II, Naples, 80131, Italy
| | - Mariantonia Maglio
- Department of Translational Medical Science (Section of Paediatrics) and ELFID (European Laboratory for the Investigation of Food-Induced Disease), University of Naples, Federico II, Naples, 80131, Italy
| | - Renata Auricchio
- Department of Translational Medical Science (Section of Paediatrics) and ELFID (European Laboratory for the Investigation of Food-Induced Disease), University of Naples, Federico II, Naples, 80131, Italy
| | - Cristiana De Musis
- Department of Translational Medical Science (Section of Paediatrics) and ELFID (European Laboratory for the Investigation of Food-Induced Disease), University of Naples, Federico II, Naples, 80131, Italy
| | - Valentina Discepolo
- Department of Translational Medical Science (Section of Paediatrics) and ELFID (European Laboratory for the Investigation of Food-Induced Disease), University of Naples, Federico II, Naples, 80131, Italy
| | - Erasmo Miele
- Department of Translational Medical Science (Section of Paediatrics) and ELFID (European Laboratory for the Investigation of Food-Induced Disease), University of Naples, Federico II, Naples, 80131, Italy
| | - Bana Jabri
- Department of Medicine, University of Chicago, Chicago, Illinois, 60637, USA
| | - Riccardo Troncone
- Department of Translational Medical Science (Section of Paediatrics) and ELFID (European Laboratory for the Investigation of Food-Induced Disease), University of Naples, Federico II, Naples, 80131, Italy
| | - Salvatore Auricchio
- Department of Translational Medical Science (Section of Paediatrics) and ELFID (European Laboratory for the Investigation of Food-Induced Disease), University of Naples, Federico II, Naples, 80131, Italy
| | - Maria Vittoria Barone
- Department of Translational Medical Science (Section of Paediatrics) and ELFID (European Laboratory for the Investigation of Food-Induced Disease), University of Naples, Federico II, Naples, 80131, Italy.
| |
Collapse
|
4
|
Qaisar N, Jurczyk A, Wang JP. Potential role of type I interferon in the pathogenic process leading to type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 2018; 25:94-100. [PMID: 29369915 PMCID: PMC5836805 DOI: 10.1097/med.0000000000000399] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
PURPOSE OF REVIEW Understanding the relationship between viral infections and the development of type 1 diabetes (T1D) is essential for T1D prevention. Virus-induced innate immune responses, specifically type I interferon (IFN-I) and the IFN gene signature, orchestrate early events of β-cell dysfunction preceding islet autoimmunity. We summarize recent advances in how IFN-I and the IFN gene signature can drive T1D development. RECENT FINDINGS IFN-I, particularly IFN-α, and the IFN gene signature have been detected in islets and peripheral blood of T1D patients. T1D risk genes in the IFN-I signaling pathway regulate antiviral responses in β cells driven by IFN-I and proinflammatory cytokines. Polymorphisms in these genes may cause chronic dysregulated IFN signaling in islets, characterized by hyperexpression of IFN-I, the IFN gene signature, and major histocompatibility complex class I during viral infection. Islet-cell inflammation mediated by aberrant IFN signaling drives β-cell apoptosis by initiating autoreactivity against β-cell antigens. The profound elevation in IFN-I and the IFN gene signature observed in some forms of T1D are also seen in a novel group of human autoimmune and autoinflammatory diseases called interferonopathies. SUMMARY Despite significant advances, further studies are required to functionally dissect the mechanisms by which excessive IFN-I contributes to the evolution of autoimmunity that destroys β cells.
Collapse
Affiliation(s)
- Natasha Qaisar
- Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605
| | - Agata Jurczyk
- Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605
| | - Jennifer P. Wang
- Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605
- Corresponding author: Jennifer P. Wang, M.D., Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, Phone: 508-856-8414, Fax: 508-856-6176,
| |
Collapse
|
5
|
Schulte BM, Gielen PR, Kers-Rebel ED, Prosser AC, Lind K, Flodström-Tullberg M, Tack CJ, Elving LD, Adema GJ. Enterovirus Exposure Uniquely Discriminates Type 1 Diabetes Patients with a Homozygous from a Heterozygous Melanoma Differentiation-Associated Protein 5/Interferon Induced with Helicase C Domain 1 A946T Genotype. Viral Immunol 2016; 29:389-97. [PMID: 27482829 DOI: 10.1089/vim.2015.0140] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
Abstract
In children at risk for type 1 diabetes, innate immune activity is detected before seroconversion. Enterovirus infections have been linked to diabetes development, and a polymorphism (A946T) in the innate immune sensor recognizing enterovirus RNA, interferon-induced with helicase C domain 1/melanoma differentiation-associated protein 5, predisposes to disease. We hypothesized that the strength of innate antienteroviral responses is affected in autoimmune type 1 diabetes patients and linked to the A946T polymorphism. We compared induction of interferon-stimulated genes (ISGs) in peripheral blood mononuclear cells (PBMCs) and dendritic cells (DCs) in healthy individuals and diabetes patients upon stimulation with enterovirus, enterovirus-antibody complexes, or ligands mimicking infection in relation to the A946T polymorphism. Overall, PBMCs of diabetes patients and healthy donors showed comparable ISG induction upon stimulation. No differences were observed in DCs. Interestingly, the data imply that the magnitude of responses to enterovirus and enterovirus-antibody complexes in PBMCs is critically influenced by the A946T polymorphism and elevated in heterozygotes compared to TT homozygous individuals in autoimmune diabetes patients, but not healthy controls. These data imply an intrinsic difference in the responses to enterovirus and enterovirus-antibody complexes in diabetes patients carrying a TT risk genotype compared to heterozygotes that may influence control of enterovirus clearance.
Collapse
Affiliation(s)
- Barbara M Schulte
- 1 Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, the Netherlands
| | - Paul R Gielen
- 1 Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, the Netherlands
| | - Esther D Kers-Rebel
- 1 Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, the Netherlands
| | - Amy C Prosser
- 1 Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, the Netherlands
| | - Katharina Lind
- 2 Department of Medicine HS, Karolinska Institutet , The Center for Infectious Medicine, Stockholm, Sweden
| | - Malin Flodström-Tullberg
- 2 Department of Medicine HS, Karolinska Institutet , The Center for Infectious Medicine, Stockholm, Sweden
| | - Cees J Tack
- 3 Department of Internal Medicine, Radboud University Medical Center , Nijmegen, the Netherlands
| | - Lammy D Elving
- 3 Department of Internal Medicine, Radboud University Medical Center , Nijmegen, the Netherlands
| | - Gosse J Adema
- 1 Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, the Netherlands
| |
Collapse
|
6
|
Semple F, MacPherson H, Webb S, Kilanowski F, Lettice L, McGlasson SL, Wheeler AP, Chen V, Millhauser GL, Melrose L, Davidson DJ, Dorin JR. Human β-Defensin 3 [corrected] Exacerbates MDA5 but Suppresses TLR3 Responses to the Viral Molecular Pattern Mimic Polyinosinic:Polycytidylic Acid. PLoS Genet 2015; 11:e1005673. [PMID: 26646717 PMCID: PMC4672878 DOI: 10.1371/journal.pgen.1005673] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2015] [Accepted: 10/26/2015] [Indexed: 11/19/2022] Open
Abstract
Human β-defensin 3 (hBD3) is a cationic host defence peptide and is part of the innate immune response. HBD3 is present on a highly copy number variable block of six β-defensin genes, and increased copy number is associated with the autoimmune disease psoriasis. It is not known how this increase influences disease development, but psoriasis is a T cell-mediated disease and activation of the innate immune system is required for the initial trigger that leads to the amplification stage. We investigated the effect of hBD3 on the response of primary macrophages to various TLR agonists. HBD3 exacerbated the production of type I Interferon-β in response to the viral ligand mimic polyinosinic:polycytidylic acid (polyI:C) in both human and mouse primary cells, although production of the chemokine CXCL10 was suppressed. Compared to polyI:C alone, mice injected with both hBD3 peptide and polyI:C also showed an enhanced increase in Interferon-β. Mice expressing a transgene encoding hBD3 had elevated basal levels of Interferon-β, and challenge with polyI:C further increased this response. HBD3 peptide increased uptake of polyI:C by macrophages, however the cellular response and localisation of polyI:C in cells treated contemporaneously with hBD3 or cationic liposome differed. Immunohistochemistry showed that hBD3 and polyI:C do not co-localise, but in the presence of hBD3 less polyI:C localises to the early endosome. Using bone marrow derived macrophages from knockout mice we demonstrate that hBD3 suppresses the polyI:C-induced TLR3 response mediated by TICAM1 (TRIF), while exacerbating the cytoplasmic response through MDA5 (IFIH1) and MAVS (IPS1/CARDIF). Thus, hBD3, a highly copy number variable gene in human, influences cellular responses to the viral mimic polyI:C implying that copy number may have a significant phenotypic effect on the response to viral infection and development of autoimmunity in humans. Defensins are classically known as antimicrobial peptides due to their ability to rapidly kill pathogens including bacteria, viruses and fungi. They are produced in the presence of infectious agents at body surfaces exposed to the environment. Increasingly, their functional repertoire is expanding, and they have been shown to modulate the immune system. In humans, there is a block of six β-defensin genes that varies in copy number in the population. Individuals with an increased number of β-defensin genes have an increased likelihood of developing the skin autoimmune disease psoriasis. It is not known how this increase in gene copy number influences development of the disease, and psoriasis is a complex interplay of genomic and environmental factors that trigger disease progression and include exposure to viruses. We examined whether a molecular pattern characteristic of viruses produces an altered immune response in the presence of the defensin human β-defensin 3 (hBD3). We find that hBD3 triggers a larger interferon defence response to this viral mimic by increasing accessibility to a cellular receptor that recognises viral patterns. Interferon is known to be important in autoimmunity and our work may explain why individuals with increased β-defensin number are predisposed to develop psoriasis.
Collapse
Affiliation(s)
- Fiona Semple
- MRC Centre for Inflammation Research, University of Edinburgh, Queen’s Medical Research Institute (QMRI), Edinburgh, United Kingdom
- MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine (IGMM), University of Edinburgh, Edinburgh, United Kingdom
| | - Heather MacPherson
- MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine (IGMM), University of Edinburgh, Edinburgh, United Kingdom
| | - Sheila Webb
- MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine (IGMM), University of Edinburgh, Edinburgh, United Kingdom
| | - Fiona Kilanowski
- MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine (IGMM), University of Edinburgh, Edinburgh, United Kingdom
| | - Laura Lettice
- MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine (IGMM), University of Edinburgh, Edinburgh, United Kingdom
| | - Sarah L. McGlasson
- MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine (IGMM), University of Edinburgh, Edinburgh, United Kingdom
| | - Ann P. Wheeler
- MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine (IGMM), University of Edinburgh, Edinburgh, United Kingdom
| | - Valerie Chen
- Department of Chemistry and Biochemistry, University of California, Santa Cruz, Santa Cruz, California, United States of America
| | - Glenn L. Millhauser
- Department of Chemistry and Biochemistry, University of California, Santa Cruz, Santa Cruz, California, United States of America
| | - Lauren Melrose
- MRC Centre for Inflammation Research, University of Edinburgh, Queen’s Medical Research Institute (QMRI), Edinburgh, United Kingdom
| | - Donald J. Davidson
- MRC Centre for Inflammation Research, University of Edinburgh, Queen’s Medical Research Institute (QMRI), Edinburgh, United Kingdom
| | - Julia R. Dorin
- MRC Centre for Inflammation Research, University of Edinburgh, Queen’s Medical Research Institute (QMRI), Edinburgh, United Kingdom
- MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine (IGMM), University of Edinburgh, Edinburgh, United Kingdom
- * E-mail:
| |
Collapse
|